Other headlinesFuji lands multiple XR deal
Merge bids $22M for Confirma
Merge Healthcare is making a $22 million bid for privately held Confirma, a developer of computer-aided detection software for the analysis of breast and prostate MR studies. If the all-stock deal goes through, as expected in September, 5.6 million shares of Merge will trade hands at an estimated value of $3.897 per share, giving Confirma investors an 8.5% stake in Merge. Short-term synergies cited by Merge when the company announced the proposed deal include leveraging international and OEM distribution channels to increase the customer base beyond the 1200 Confirma software packages currently installed. Merge would also seek to integrate Confirma and Merge breast imaging solutions. In the midterm, CAD-based technologies from Confirma may be used in clinical trials, a market segment that will open up with last month’s acquisition of etrials Worldwide. Over the long term, Merge wants to expand the use of CAD to improve efficiency in medical practice, namely in established markets where imaging costs are coming under fire.
Fuji lands multiple XR deal
FujiFilm Medical Systems USA has installed five FCR Go digital portable x-ray systems at Halifax Medical Center in Daytona Beach, FL. The system uses computed radiography plates and an onboard reader to perform radiography throughout the hospital, which provides a 24-hour emergency department, the largest in the state of Florida, and East Central Florida’s first and only pediatric intensive care unit. Halifax is the area's only Level II Trauma Center.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.